The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

23 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HTEBI
Suven Life Sciences
Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists.EBI
Suven Life Sciences
Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N1-arylsulfonyl indole derivatives as 5-HT6 receptor ligands.EBI
Suven Life Sciences
Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT6 receptor antagonists.EBI
Suven Life Sciences
N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.EBI
Suven Life Sciences
Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.EBI
Suven Life Sciences
Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.EBI
Suven Life Sciences
Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT(6) receptor antagonists.EBI
Suven Life Sciences
Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HTEBI
Suven Life Sciences
Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression.EBI
Suven Life Sciences
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine HEBI
Suven Life Sciences
Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.EBI
Suven Life Sciences
Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HTEBI
Suven Life Sciences
PYRAZOLO FUSED RING COMPOUND AND USE THEREOFBDB
Soter Biopharma
FGFR4 inhibitor and preparation method and use thereofBDB
Jiangsu Hansoh Pharmaceutical Group
Spiroheptanyl hydantoins as rock inhibitorsBDB
Bristol-Myers Squibb
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofBDB
Topadur Pharma
Bicyclic compound and use thereofBDB
Sk Biopharmaceuticals
Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.BDB
Birla Institute of Technology
5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesBDB
Merck Sharp & Dohme
Indolizinone based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereofBDB
Council of Scientific & Industrial Research
Design, Synthesis and Biological Evaluation of Peptidyl Epoxyketone Proteasome Inhibitors Composed of ??????-amino Acids.BDB
Zhejiang University
Pseudodipeptides as MMP inhibitorsBDB
French Alternative Energies and Atomic Energy Commission